Clinical trial
Comparison of the Efficacy of Femoral and Sciatic Nerve Blocks Added to Obturator Nerve Block in Preventing the Obturator Reflex
NCT07922941 is registered in ClinicalTrials.gov with Tuna Erturk as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, 14-day trial. Card required. Your first charge is when the trial ends. See pricing
Registry record
As filed in ClinicalTrials.gov.
- Title
- Comparison of the Efficacy of Femoral and Sciatic Nerve Blocks Added to Obturator Nerve Block in Preventing the Obturator Reflex
- Lead sponsor
- Tuna Erturk
- Phase
- Not applicable
- Overall status
- Not yet recruiting
- Start date
- November 2, 2026
- Completion date
- February 2, 2027
- Enrollment
- 90 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
obturator reflex
Arms
As registered; 3 arms.
-
Obturator Nerve Block (ONB)
Patients will receive an ultrasound-guided obturator nerve block.
-
ONB + FNB
Patients will receive ultrasound-guided obturator and femoral nerve blocks.
-
ONB + FNB + SNB
Patients will receive ultrasound-guided obturator, femoral, and sciatic nerve blocks.
Primary endpoints
Registered primary outcome measures; 1 primary.
-
Number of Participants With at Least One Intraoperative Adductor Muscle Contraction
Participants experiencing at least one adductor muscle contraction during transurethral bladder tumor resection will be recorded. The number and proportion of affected participants will be compared across the three groups.